Using both tail vein injection and syngeneic orthotopic transplantation models, we demonstrated that modulating MUC15 levels effectively regulated tumor metastasis and ECM remodeling, highlighting its potential as a therapeutic target for metastatic control. The gene discussed is MUC15; the disease is neoplasm.